Skip to main content

Skin Cancer Checker App, SkinVision, Snags $3.4M To Move Beyond Moles

Image
By

Can an app warn you that you might have skin cancer? Digital health startup SkinVision is using smartphone tech and vision algorithms to allow consumers to track changes to their moles. Users of its iOS and Android apps, which have been downloaded some 200,000 times since launch back in 2011, take a photo of a mole and the app then performs a visual analysis, with the aim of identifying suspicious growths such as melanoma.
“Skin cancer grows chaotically and potential suspicious moles are identified based on signs of non-natural growth,” explains CEO Dick Uyttewaal. “The algorithm within the online assessment reviews signs of non-natural growth of skin lesions and is based on an established mathematical methodology in biology called fractal geometry.
“The algorithm currently looks at seven different criteria and will be further improved based on the continuous growth in our database (currently in excess of 1 million pictures).”
Moles are rated using a simple traffic light system (using a red, orange or green risk rating). The app lets users store photos in multiple folders so they can track different moles over time.
“A changing mole (color, size, symmetry etc.) is a clear sign that something is wrong and that the person should visit a doctor immediately,” he adds.
How accurate is the SkinVision tech at identifying melanoma? Uyttewaal says it’s as good as the “average eye of a dermatologist”, noting also that it’s the only such skin cancer detector app to have obtained CE certification in Europe.
“Medical studies show that the sensitivity of dermatologists to recognize melanoma is 70 to 90 per cent… [A 2014 study of the app, conducted by the university clinic of Ludwig Maximillian University] shows an overall accuracy to recognize melanoma with the red rating of 83 per cent, and a sensitivity to recognize melanoma of 73 per cent (with red rating) and 92 per cent (with red and orange ratings),” says Uyttewaal.
“The study was based on the SkinVision technology that was looked at November 2012, and since the study we have continued to deliver enhancements to the technology,” he adds.
SkinVision is now announcing what a terms a late Series A/early Series B funding round of €3 million ($3.4M), bringing its total raised to date to between €5 million and €6 million. Since the initial app launch, the business has grown into what Uyttewaal terms a “solutions platform”, monetizing its software via different monthly subscription pricing models — which vary depending on the country. Some free usage is possible, although a subscription payment model is its primary monetization channel at this point. (And one which has triggered a rash of negative reviews of its apps.)
“Consumers are only starting to get used to paying for health related applications. For those that provide support in a health risk area, and have been clinically proven, consumers have begun to pay monthly fees in excess of the SkinVision subscription, because they recognise the value and importance of managing potentially risky lesions early to prevent the need for longer term, more invasive and costly treatment,” argues Uyttewaal.
“I would also like to add that SkinVision does not use customer data for commercial purposes,” he adds.
SkinVision’s new tranche of financing comes from European pharmaceutical firm LEO Pharma, whose business unsurprisingly also has a strong focus on dermatology, so there’s obvious synergies to be leveraged there. Also part of the round: prior investor and SkinVision majority shareholder Personal Health Solutions Capital, a Dutch investment firm focusing on consumer-centric digital health solutions.
SkinVision notes specifically that a key impetus for the investment is widening applications for its technology — so applying it to track and assess other serious skin conditions, beyond moles and melanomas. So again, having a pharma company as an investor aligns with its expansion plans.
Commenting on the funding in a statement, LEO Pharma’s SVP of global development, Kim Kjoeller, notes: “The Internet is dramatically changing how consumers manage their health and that creates new opportunities for us to deliver innovative, value-added services. We are very pleased to collaborate with SkinVision, because we will gain unique learnings about the convergence of digital technologies with medical applications.
“The coming years will see an ever changing and increasingly digital health care environment and LEO Pharma wants to be at the forefront of that trend. This is a huge opportunity for the European technology and pharmaceutical industries to become world leaders.”
SkinVision’s new financing will also be used to expand into new geographical markets, and to try to establish stronger ties with national healthcare systems in select markets, adds Uyttewaal.
SkinVision

Comments

Post a Comment

Popular posts from this blog

The EHang 184 Is A Human-Sized Drone Taking Off At CES

By
We’ve seen some pretty cool stuff on day 1 of CES 2016, but probably nothing more eye-catching than the EHang 184, a human-sized drone built by the Chinese UAV company  EHang . Yes you heard right — a giant autonomous drone that fits a human. It’s basically what you would expect to see if someone shrunk you down to the size of a LEGO and stuck you next to a DJI Inspire. Except no one was shrunk, and the giant flying machine was sitting smack in the middle of the CES drone section. EHang, which was founded in 2014 and has raised about $50M in venture fundingto date, was pretty gung-ho about telling everyone at CES that the 184 was the future of personal transport. And for the most part, people were too in awe to question them. But the reality is that the company probably was using the 184 as more of a marketing tool for their standard-sized drones like the  Ghost . Not that we’re saying that the 184 will never be a real thing, just that it probably isn’t co...
Post a Comment
Read more

Western Union Brings Money Transfer And Its Tricky Fees To Chat Apps

By
Remittance has always been a shady business. Migrant workers need to send money they earn home to their families, but get hit with fine print fees so less cash comes out the other side than they might assume. Remittance companies earn extra by keeping the margin between their own made up exchange rate and the real one. Western Union is the best known remittance company, with 500,000 brick-and-mortar locations around the world. But tech startups like TransferWise, Azimo, and WorldRemit are gunning for the business. They hope to increase convenience and reduce fees to lure customers away from Western Union, Moneygram, and other old-school remittance providers. So  Western Union  is going digital thanks to partnerships with big messaging apps. It launched its Western Union Connect system in October last year, followed by a partnership with WeChat for sending up to $100. Now it’s getting into bed with  Viber , which has over 664 million “unique” users, thou...
Post a Comment
Read more

Following Patent Deal, Every Time Apple Sells An iPhone, Ericsson Gets A Bit Of Money

By
Telecommunications infrastructure company Ericsson just  announced  that it has reached an agreement with Apple over an ongoing patent dispute. For the next seven years, Apple will pay a fraction of its iPhone and iPad profit to Ericsson in royalties. Back in February, Ericsson filed suits in many different jurisdictions for patent infringement (the International Trade Commission, the U.S. District Court for the Eastern District of Texas, the U.S. District Court for the Northern District of California, as well as courts in the U.K., Germany and the Netherlands). According to the Swedish company, Apple has been violating 41 patents over the past few years with its iPhone and iPad, in particular patents related to GSM, UMTS and LTE technologies. As expected, the two companies have reached an agreement and Ericsson is dropping all of its lawsuits. Today’s news isn’t particularly surprising as Ericsson holds more than 35,000 patents. Many of them are related to wireles...
Post a Comment
Read more

Android Oreo vs iOS 11: What’s different and what’s the same?

By
Google just announced Android Oreo and it packs a handful of new features. Some are at the system level and speed up the system and extend the battery life, while others are features that will change the way users interact with their phone. A lot of these features should be familiar to iPhone and iPad owners. Normally Apple is the one accused of copying Android, but for Android Oreo, Google lifted a handful of features straight from iOS, while a couple of new functions are hitting Android before iOS.                                                                                                                     Notifications Google cribbed iOS for Android’s new notification scheme. In An...
Post a Comment
Read more

NVBOTS Wants To Make 3D Printers As Easy As Toasters

By
Right now 3D printing curriculums, if they exist, are fairly sparse. Putting a two thousand dollar machine in front of a grade schooler usually ends up in a lot of 3D printed Yoda heads and not much education while the learning curve for most 3D design tools is steep. That’s what the founders of NVBOTS, AJ Perez, Forrest Pieper, Christopher Haid, and Mateo Peña Doll, are looking to solve. Their product, the  NVPRO , is a 3D printer with a few interesting features. The two most interesting are the automatic removal system which pops parts off of the build plate when they are done and a built-in print server that allows you to print from any device. This means you can run large batches of prints from different users with each part popping off as its printed. This means a class of students can send jobs to a printer and then pick them up just as they would a laser printer. The printer also supports a central “admin” who can check jobs before they are printed as and offers a ...
Post a Comment
Read more